Anxiety disorders, Depression treatment and Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Anxiety disorders

Depression treatment

Manufacturing

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

MARCH 15, 2025

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). accepting personal or office gifts or corporate donations from industry.

Neurotransmitters and mental health

Neurotransmitters and mental health Trauma and the brain Manufacturing Pharmaceuticals

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Mad in America

SEPTEMBER 18, 2024

In addition, since STAR*D’s publication, the prescription of these drugs is generating and exacerbating depression more than alleviating it. We showed how STAR*D’s authors had manipulated the data to manufacture fraudulent results. In 2010, I was one of the authors of a published critique of the STAR*D study’s reported findings.

Aging and mental health

Aging and mental health Cognitive Behavioral Therapy Manufacturing Anxiety disorders

Mental Health Clinicians

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Stay Connected